SEC Company Response from Adamis Pharmaceuticals Corp (DMKPQ) (CIK 0000887247) — Jul 6, 2005
Adamis Pharmaceuticals Corp (DMKPQ) (CIK 0000887247)
Date: July 6, 2005 · CIK: 0000887247 · Accession: 0001047469-05-018946
AI Filing Summary & Sentiment
File numbers found in text: 333-125787
Referenced dates: June 24, 2005
Letter
Via EDGAR and Overnight Delivery Securities and Exchange Commission Division of Corporate Finance Attention: Jeffrey P. Riedler Mail Stop 0309 Re:Cellegy Pharmaceuticals, Inc. Registration Statement on Form S-3, filed on June 14, 2005 File No. 333-125787
Dear Mr. Riedler:
On behalf of Cellegy Pharmaceuticals, Inc., a Delaware corporation ("Cellegy"), we enclose for your review Pre-Effective Amendment No. 1 to the above-referenced Registration Statement on Form S-3 ("Amendment No. 1"). Amendment No. 1, together with this letter, responds to the comments in the Staff's letter dated June 24, 2005. We have enclosed with the overnight delivered copy of this letter a conformed, marked courtesy copy of Amendment No. 1. The responses below have been numbered to correspond with the comments in the Staff's June 24, 2005 letter.
FORM S-3
COMMENT
Please incorporate by your reference your most recent Form 10-K, which includes Part III information filed on April 29, 2005.
RESPONSE TO COMMENT 1
As requested by the Staff, the Form 10-K/A has been specifically incorporated by reference on page 25.
Conclusion
Cellegy desires that the registration statement be declared effective as soon as possible. If you have any further comments or questions, please contact Todd Wilson or the undersigned at (916) 558-6000.
Very truly yours,
weintraub genshlea chediak sproul
Show Raw Text
CORRESP
1
filename1.htm
[LETTERHEAD OF WEINTRAUB GENSHLEA CHEDIAK SPROUL]
July 6,
2005
Via EDGAR and Overnight Delivery
Securities
and Exchange Commission
Division of Corporate Finance
450 Fifth Street, N.W.
Washington, D.C. 20549
Attention: Jeffrey P. Riedler
Mail Stop 0309
Re:Cellegy Pharmaceuticals, Inc.
Registration Statement on Form S-3, filed on June 14, 2005
File No. 333-125787
Dear
Mr. Riedler:
On
behalf of Cellegy Pharmaceuticals, Inc., a Delaware corporation ("Cellegy"), we enclose for your review
Pre-Effective Amendment No. 1 to the above-referenced Registration Statement on Form S-3 ("Amendment
No. 1"). Amendment No. 1, together with this letter, responds to the comments in the Staff's letter dated June 24, 2005. We have enclosed with the
overnight delivered copy of this letter a conformed, marked courtesy copy of Amendment No. 1. The responses below have been numbered to correspond with the comments in the Staff's
June 24, 2005 letter.
FORM S-3
COMMENT
1
Please
incorporate by your reference your most recent Form 10-K, which includes Part III information filed on April 29, 2005.
RESPONSE
TO COMMENT 1
As
requested by the Staff, the Form 10-K/A has been specifically incorporated by reference on page 25.
Conclusion
Cellegy desires that the registration statement be declared effective as soon as possible. If you have any further comments or questions, please contact Todd
Wilson or the undersigned at (916) 558-6000.
Very truly yours,
weintraub genshlea chediak sproul
a law corporation
/s/ C. KEVIN KELSO C. Kevin Kelso
CKK/rtw
Enclosure
cc.
Robert J. Caso